Supplementary Figure 1 from Combination of Anti-HER3 Antibody MM-121/SAR256212 and Cetuximab Inhibits Tumor Growth in Preclinical Models of Head and Neck Squamous Cell Carcinoma
Year: 2023
Type: supplementary-materials
Abstract: PDF file - 96KB, Sensitivity of HNSCC cell lines to MM-121 and cetuximab.
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362621796